Japan - Drinking Coffee May Offer Relief To Dry Eye Sufferers, Study

According to a Japanese study, caffeine may offer relief to millions of dry eyes sufferers worldwide, in particular a subset of people with genetic variations in two genes.

Japanese researchers have shown that caffeine may offer relief to millions who suffer from dry eye syndrome around the world, in particular a subset of people with genetic variations in two genes.

This common eye condition, caused by the inability of the eye to produce enough tears or increased evaporation of tears from the eye surface, affects about four million people age 50 and older in the United States.

For many, dry eye syndrome is simply uncomfortable and annoying, but for others it escalates into a vision-threatening disease.

Current treatment options range from simple warm compresses, eye washes and artificial tears to medications and tear drainage devices.

Dr. Reiko Arita of the University of Tokyo School of Medicine was motivated to pursue this study based on a previous study reporting that caffeine users had a lower risk of dry eyes than non-caffeine users: 13 percent of users had dry eye in comparison with nearly 17 percent of non-users.

Apart from knowing that caffeine increases the secretion of saliva and digestive juices, the team was also aware that individuals respond differently to caffeine. The team analyzed DNA samples of the participants for two genetic variations which are known to play a role in metabolizing caffeine.

In the new study published in the journal Ophthalmology, the team showed that participants with genetic variations in the ADORA2A and CYP1A2 genes had greater tear production after caffeine consumption.

“If confirmed by other studies, our findings on caffeine should be useful in treating dry eye syndrome,” said Arita. “At this point, though, we would advise using it selectively for patients who are most sensitive to caffeine’s stimulating effects.”

The article can be found at: Arita R et al. (2012) Caffeine Increases Tear Volume Depending on Polymorphisms within the Adenosine A2a Receptor Gene and Cytochrome P450 1A2.

Yuka Suzuki | Health & Medicine

AsianScientist

Source: American Academy of Ophthalmology.